{
  "ticker": "EMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959566",
  "id": "02959566",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250618",
  "time": "0944",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250618/pdf/06kvr5gz5mt7w0.pdf",
  "summary": "### **Capital Raising Announcement Summary**  \n- **Structure**: Placement with attached options  \n- **Total Capital Raised**:  \n  - **Ordinary Shares (EMD)**: 172,916,667 shares at AUD 0.024 per share (**AUD 4.15m total**)  \n  - **Attaching Options**:  \n    - 55,555,556 unlisted options (exercise price AUD 0.05, expiry 18/2/2027) \u2013 1:3 with Placement Shares.  \n    - 2,500,000 unlisted options (same terms) to Lead Manager (GBA Capital).  \n    - 2,083,333 unlisted options (same terms) for investor relations services.  \n- **Timetable**:  \n  - **Proposed Issue Date**: 25/6/2025  \n  - **Shareholder Approval Date (for Tranche 2)**: Estimated 18/8/2025 (if required).  \n- **Use of Proceeds**: Fund expanded treatment programs (including Medibank agreement) and working capital.  \n- **Key Conditions**:  \n  - 71.29m shares issued under 15% placement capacity (no approval required).  \n  - 48.92m shares under 10% capacity (7.1A).  \n\n**Notes**: No underwriting; Lead Manager fee: 2% on total funds (+4% on self-introduced capital).",
  "usage": {
    "prompt_tokens": 3927,
    "completion_tokens": 303,
    "total_tokens": 4230,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T23:55:32.844666"
}